
Sign up to save your podcasts
Or


Bloomberg Intelligence Medtech Analyst Matthew Henriksson discusses development of plant based formula alternative and the potential ability to disrupt this market with Kate Farms CEO Brett Matthews.
By Bloomberg4.6
1414 ratings
Bloomberg Intelligence Medtech Analyst Matthew Henriksson discusses development of plant based formula alternative and the potential ability to disrupt this market with Kate Farms CEO Brett Matthews.

1,296 Listeners

536 Listeners

406 Listeners

2,175 Listeners

427 Listeners

1,105 Listeners

2,342 Listeners

970 Listeners

341 Listeners

196 Listeners

65 Listeners

30 Listeners

551 Listeners

512 Listeners

355 Listeners

4 Listeners

58 Listeners

233 Listeners

230 Listeners

69 Listeners

150 Listeners

81 Listeners

85 Listeners

403 Listeners

19 Listeners

14 Listeners

7 Listeners

2 Listeners

119 Listeners